CMS Announces Decision to Cover Lung Cancer Screening for High-Risk Individuals
Tue Mar 29 13:00:25 CDT 2016
On behalf of Medtronic, I’d like to extend our congratulations to you and all those in the healthcare communities you serve for the landmark decision announced by the Center for Medicare & Medicaid Services (CMS) on Thursday, February 5, 2015. This important decision requires Medicare coverage of low-dose computed tomography (CT) lung cancer screening for approximately four million at-risk beneficiaries – a huge victory for patients and healthcare providers across the country.
For so many years, patients have been without a standardized early warning system for this devastating disease – until now. With this coverage decision, together we can celebrate the birth of newfound hope for patients through early action. Details and information about this decision are available on the CMS website.
Now that coverage is on its way, and with the potential for millions of patients to be diagnosed at earlier stages, a responsible and evidence-based approach to patient care is vital. We understand that the development and enhancement of screening programs and care pathways may be of critical importance to your institution, and that screening is most effective when it is part of a comprehensive lung cancer program.
To support you through this process, we extend an invitation to our webinar: Coverage is Here: Are You Ready for New Lung Cancer Screening Patients? This webinar covers the importance and implications of the CMS decision, essential components needed for a lung screening program, and feature a case study of a lung program that has successfully implemented these recommendations. We hope you will join us.
We commend CMS in arriving at this important decision - that will enable earlier detection of lung cancer and may increase survival - changing the face of lung cancer for patients.
Congratulations again, on behalf of all of us at Medtronic.
Michael Tarnoff, MD, FACS
Webinar: Coverage is Here: Are You Ready for New Lung Cancer Screening Patients?